Loading…
Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
BACKGROUND: Prognostic value or clinical implications of fluid status monitoring in liver cirrhosis are not fully elucidated. Tolvaptan, an orally available, selective vasopressin V2-receptor antagonist approved for hyponatremia in the United States and European Union. It is also used for cirrhotic...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
BioMed Central
2020
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059268/ https://www.ncbi.nlm.nih.gov/pubmed/32138675 http://dx.doi.org/10.1186/s12876-020-01205-2 |